Search Results - "Lioznov, Dmitry A"

Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR by Yolshin, Nikita D, Komissarov, Andrey B, Varchenko, Kirill V, Musaeva, Tamila D, Fadeev, Artem V, Lioznov, Dmitry A

“…Whole genome sequencing (WGS) is considered the best instrument to track both virus evolution and the spread of new, emerging variants. However, WGS still does…”
Get full text

Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine by Kordyukova, Larisa V, Moiseenko, Andrey V, Serebryakova, Marina V, Shuklina, Marina A, Sergeeva, Maria V, Lioznov, Dmitry A, Shanko, Andrei V

“…Inactivated vaccines are promising tools for tackling the COVID-19 pandemic. We applied several protocols for SARS-CoV-2 inactivation (by β-propiolactone,…”
Get full text

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines by Sergeeva, Mariia V, Romanovskaya-Romanko, Ekaterina A, Krivitskaya, Vera Z, Kudar, Polina A, Petkova, Nadezhda N, Kudria, Kira S, Lioznov, Dmitry A, Stukova, Marina A, Desheva, Yulia A

“…Neuraminidase (NA)-based immunity could reduce the harmful impact of novel antigenic variants of influenza viruses. The detection of neuraminidase-inhibiting…”
Get full text

Impact of illicit opioid use on T cell subsets among HIV-infected adults by Edelman, E Jennifer, So-Armah, Kaku, Cheng, Debbie M, Doyle, Margaret F, Coleman, Sharon M, Bridden, Carly, Gnatienko, Natalia, Lioznov, Dmitry A, Blokhina, Elena, Freiberg, Matthew S, Krupitsky, Evgeny M, Emu, Brinda, Samet, Jeffrey H

“…Opioids have immunosuppressive properties, yet opioid effects on T cell abnormalities consistent with the immune risk phenotype among HIV-infected individuals…”
Get full text

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial by Kudriavtsev, Aleksandr V, Vakhrusheva, Anna V, Kryuchkov, Nickolay A, Frolova, Maria E, Blagodatskikh, Konstantin A, Ivanishin, Taras V, Djonovic, Milana, Romanovskaya-Romanko, Ekaterina A, Kovalenko, Anton N, Lioznov, Dmitry A, Zubkova, Tatiana G, Teplykh, Svetlana V, Oseshnyuk, Rodion A, Stukova, Marina A, Isaev, Artur A, Krasilnikov, Igor V

“…COVID-19, being a life-threatening infection that evolves rapidly, remains a major public health concern calling for the development of vaccines with broad…”
Get full text

A Novel Approach for COVID-19 Patient Condition Tracking: From Instant Prediction to Regular Monitoring by Bakin, Evgeny A, Stanevich, Oksana V, Chmelevsky, Mikhail P, Belash, Vasily A, Belash, Anastasia A, Savateeva, Galina A, Bokinova, Veronika A, Arsentieva, Natalia A, Sayenko, Ludmila F, Korobenkov, Evgeny A, Lioznov, Dmitry A, Totolian, Areg A, Polushin, Yury S, Kulikov, Alexander N

“…The aim of this research is to develop an accurate and interpretable aggregated score not only for hospitalization outcome prediction (death/discharge) but…”
Get full text

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial by Halperin, Scott A, Ye, Lingyun, MacKinnon-Cameron, Donna, Smith, Bruce, Cahn, Pedro E, Ruiz-Palacios, Guillermo M, Ikram, Aamer, Lanas, Fernando, Lourdes Guerrero, M, Muñoz Navarro, Sergio Raúl, Sued, Omar, Lioznov, Dmitry A, Dzutseva, Vitalina, Parveen, Ghazala, Zhu, Fengcai, Leppan, Laura, Langley, Joanne M, Barreto, Luis, Gou, Jinbo, Zhu, Tao, Mao, Helen, Gagnon, Luc, Tran, Steven-Phay, Khan, Sarwat Tahsin, Becerra Aquino, Amalia Guadalupe, Saldaña Montemayor, Edgar Eduardo, Rivera Martínez, Norma Eréndira, Bohórquez López, Víctor Casildo, Simón Campos, J. Abraham, Pineda Cárdenas, Felipe de Jesús, Chen, Wei, Hou, Lihua, Zhang, Zhe, Corral, Gonzalo, López, Eduardo, Teijeiro, Ricardo, Alzogaray, Maria F., Zaidman, Cesar, Lopardo, Gustavo, Goecke, Bernardo, Feijooó Seoane, Rosa María, Mahmood, Sayed Faisal, Khan, Ejaz Ahmed, Akram, Jayed, Abbas, Salma, Salahuddin, Naseem, Rozhkova, Elena, Zubkova, Tatyana

“…The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic…”
Get full text

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants by Gushchin, Vladimir A., Dolzhikova, Inna V., Shchetinin, Alexey M., Odintsova, Alina S., Siniavin, Andrei E., Nikiforova, Maria A., Pochtovyi, Andrei A., Shidlovskaya, Elena V., Kuznetsova, Nadezhda A., Burgasova, Olga A., Kolobukhina, Liudmila V., Iliukhina, Anna A., Kovyrshina, Anna V., Botikov, Andrey G., Kuzina, Aleksandra V., Grousova, Daria M., Tukhvatulin, Amir I., Shcheblyakov, Dmitry V., Zubkova, Olga V., Karpova, Oksana V., Voronina, Olga L., Ryzhova, Natalia N., Aksenova, Ekaterina I., Kunda, Marina S., Lioznov, Dmitry A., Danilenko, Daria M., Komissarov, Andrey B., Tkachuck, Artem P., Logunov, Denis Y., Gintsburg, Alexander L.

“…Since the beginning of the 2021 year, all the main six vaccines against COVID-19 have been used in mass vaccination companies around the world. Virus…”
Get full text

Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19 by Sabitov, A U, Lioznov, D A, Zhdanov, K V, Tihonova, E P, Esaulenko, E V, Sorokin, P V

“…Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with…”
Get full text

Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C by Nozhkin, M S, Lioznov, D A, Antonova, T V, Gorchakova, O V, Goldstein, E M, Popova, M O, Shneyder, T V

“…The study evaluated the impact of HCV infection on the prognosis in patients with hematological malignancies. A total of 96 patients with anti-HCV antibodies…”
Get full text

Depression, substance use, viral load, and CD4+ count among patients who continued or left antiretroviral therapy for HIV in St. Petersburg, Russian Federation by Pecoraro, Anna, Mimiaga, Matthew, O'Cleirigh, Conall, Safren, Steven A., Blokhina, Elena, Verbitskaya, Elena, Yaroslavtseva, Tatiana, Ustinov, Andrey, Lioznov, Dmitry A., Zvartau, Edwin, Krupitsky, Evgeny, Woody, George E.

“…Antiretroviral therapy (ART) became more widely available in the Russian Federation in 2006 when the Global Fund made a contribution to purchase ART with a…”
Get full text

Changes in the etiological structure of severe acute respiratory viral infections in children and adults under the influence of the COVID-19 pandemic by Sominina, Anna A., Danilenko, Darya M., Komissarov, Andrey B., Pisareva, Maria M., Musaeva, Tamila D., Stolyarov, Kirill A., Afanasyeva, Olga I., Timonina, Veronika S., Venev, Evgeny V., Levanyuk, Tatiana P., Smorodintseva, Elizaveta A., Kurskaya, Olga G., Shestopalov, Alexander M., Lelenkova, Evgenya V., Semenov, Alexander V., Lioznov, Dmitry A.

“…Introduction. The traditional surveillance system for influenza and ARVI provides a general description of epidemics, but does not provide information on the…”
Get full text

HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking by Edelman, E. Jennifer, Lunze, Karsten, Cheng, Debbie M., Lioznov, Dmitry A., Quinn, Emily, Gnatienko, Natalia, Bridden, Carly, Chaisson, Christine E., Walley, Alexander Y., Krupitsky, Evgeny M., Raj, Anita, Samet, Jeffrey H.

“…The link between HIV stigma with substance use is understudied. We characterized individuals with high HIV stigma and examined whether HIV stigma contributes…”
Get full text

2020–2021 rhinovirus genetic diversity in Saint Petersburg by Ksenafontov, Andrey D., Pisareva, Maria M., Eder, Veronika A., Musaeva, Tamila D., Fadeev, Artem V., Komissarov, Andrey B., Kiseleva, Irina V., Lioznov, Dmitry A.

“…Introduction. Rhinoviruses represent one of the most common respiratory viruses and belong to the Picornoviridae family, genus Enterovirus, being divided into…”
Get full text

The 35th anniversary of the North-Western District center for AIDS prevention and control at the Saint Petersburg Pasteur Institute by Belyakov, Nikolay A., Ogurtsova, Svetlana V., Rassokhin, Vadim V., Lioznov, Dmitry A., Yastrebova, Elena B., Boeva, Ekaterina V., Totolyan, Areg A.

“…The organization of the North-Western District Center for AIDS Prevention and Control (AIDS Center) originates from the onset of the HIV epidemic in the…”
Get full text

Fast prototyping of a local fuzzy search system for decision support and retraining of hospital staff during pandemic by Bakin, Evgeny A., Stanevich, Oksana V., Danilenko, Daria M., Lioznov, Dmitry A., Kulikov, Alexander N.

“…Purpose The COVID-19 pandemic showed an urgent need for decision support systems to help doctors at a time of stress and uncertainty. However, significant…”
Get full text

Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis c and tuberculosis by Belyakov, Nikolay A., Boeva, Ekaterina V., Zagdyn, Zinaida M., Esaulenko, Elena V., Lioznov, Dmitry A., Simakina, Olga E.

“…Pathological conditions of various natures are capable of mutual aggravation, significantly affecting the overall burden of the disease, its manifestations and…”
Get full text

Epidemiology and course of infectious diseases during the covid-19 pandemic. Report 2. Interference engaged between SARS-COV-2 and acute respiratory viral infections by Boeva, Ekaterina V., Belyakov, Nikolay A., Simakina, Olga E., Danilenko, Daria M., Lioznov, Dmitry A.

“…Currently, the disease caused by the new coronavirus (COVID-19) and the possibility of co-infection with SARS-CoV-2 and other pathogens in the current epidemic…”
Get full text

Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19 by Stanevich, O V, Bakin, E A, Korshunova, A A, Gudkova, A Y, Afanasev, A A, Shlyk, I V, Lioznov, D A, Polushin, Y S, Kulikov, A N

“…To conduct a retrospective assessment of the clinical and laboratory data of patients with severe forms of COVID-19 hospitalized in the intensive care and…”
Get full text

Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort by Edelman, E. Jennifer, Cheng, Debbie M., Krupitsky, Evgeny M., Bridden, Carly, Quinn, Emily, Walley, Alexander Y., Lioznov, Dmitry A., Blokhina, Elena, Zvartau, Edwin, Samet, Jeffrey H.

“…Opioids have immunosuppressive properties, yet their impact on HIV disease progression remains unclear. Using longitudinal data from HIV-infected…”
Get full text